| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 03/11/2003 | US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 03/11/2003 | US6531479 Anti-cancer compounds |
| 03/06/2003 | WO2003017764A1 Substituted propargylamines |
| 03/06/2003 | WO2002086069A3 Secreted proteins |
| 03/06/2003 | WO2002066516A3 Antibodies that bind both bcma and taci |
| 03/06/2003 | WO2002057224A3 Synthesis and antimicrobial activityof novel dicationic 'reversed amidines' |
| 03/06/2003 | WO2001092304A3 Transporters and ion channels |
| 03/06/2003 | US20030045746 Phosphorous organic compounds and their use |
| 03/06/2003 | US20030045528 Antibacterial and antiprotozoal agents |
| 03/06/2003 | US20030045490 Therapeutic antisense phosphodiesterase inhibitors |
| 03/06/2003 | US20030045460 Orally administered peptides to ameliorate atherosclerosis |
| 03/06/2003 | US20030044773 Genetically engineering viral polypeptide; obtain nucleotide sequences coding polypeptide, insert codon, clone into vector, transform cell, detect expression of genetically engineered polypeptide |
| 03/06/2003 | US20030044414 Vaccine which neutralizes bacteria or protozoa |
| 03/05/2003 | EP1287025A1 Sheep lice, bovicola ovis, allergen treatment |
| 03/05/2003 | EP1287011A1 Hygromycin a derivatives for the treatment of bacterial and protozoal infections |
| 03/05/2003 | EP1286694A2 Genetic vaccine that mimics natural viral infection and induces long-lasting immunity to pathogens |
| 03/05/2003 | EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
| 03/05/2003 | EP1001962B8 Production of avermectin compounds |
| 03/05/2003 | EP0946515B1 Parasiticidal pyrazoles |
| 03/05/2003 | CN1401001A 5HT3 receptors of nematodes, polynucleotide molecules encoding same, and antagonists thereof |
| 03/04/2003 | US6528524 Treating the multiple drug resistance, arrhythmia, spasms and malaria; reacting hydrochloric acid with cinchonine or to cinchonine monohydrochloride in form cinchonine dihydrochloride; high purity |
| 03/04/2003 | US6528512 Cytokine specific binding protein; |
| 03/03/2003 | WO2002020496A1 2-guanidino-4-aryl-quinazoline |
| 03/03/2003 | CA2421222A1 2-guanidino-4-aryl-quinazoline |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016354A2 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/27/2003 | WO2003015773A2 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases |
| 02/27/2003 | WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | WO2003015517A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/27/2003 | WO2002102784A3 2-adamantyl-4,6-diamino-1,2-dihydro-1-aryl-1,3,5-triazine derivatives as cell prolifiration inhibitors |
| 02/27/2003 | WO2002091992A3 Targeted delivery of drugs for the treatment of parasitic infections |
| 02/27/2003 | WO2002083641A3 Amino-aza-cyclohexanes for the treatment of malaria |
| 02/27/2003 | WO2002080851A3 Chimeric vaccines |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002000691A3 Polynucleotides and polypeptides encoded thereby |
| 02/27/2003 | US20030040524 Pyrimidine compounds and methods for making and using the same |
| 02/27/2003 | US20030040497 Compositions and methods for non-parenteral delivery of oligonucleotides |
| 02/27/2003 | US20030040492 Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 02/27/2003 | US20030039689 Prodrug in polymer matrix; insertion into body |
| 02/27/2003 | DE4200555C2 Herstellung eines Kamillenextraktes mit antimikrobiellen Eigenschaften Producing a chamomile extract with antimicrobial properties |
| 02/27/2003 | CA2458890A1 Recombinant anti-plasmodium falciparum antibodies |
| 02/27/2003 | CA2458643A1 Nucleic-acid associated proteins |
| 02/27/2003 | CA2457452A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | CA2456966A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | CA2456290A1 Agonists and antagonists of 5h3-like receptors of invertebrate s as pesticides |
| 02/26/2003 | EP1284995A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 02/26/2003 | EP1284956A1 Il-8 receptor antagonists |
| 02/26/2003 | EP1284740A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono- and disaccharide-based compounds |
| 02/26/2003 | EP1284727A1 Intracorporeal medicaments for photodynamic treatment of disease |
| 02/26/2003 | EP1284725A2 Medicament for the treatment of diseases caused by parasitic protozoa |
| 02/26/2003 | EP0929571B1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 02/26/2003 | CN1399678A Human Enzymes of metalloprotease family |
| 02/26/2003 | CN1399627A Method of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/26/2003 | CN1399546A Injectable preparation for controlling fish live comprising benzoyl urea derivatives |
| 02/26/2003 | CN1399539A Adjuvant comprising polyxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 02/26/2003 | CN1399516A Novel composition |
| 02/26/2003 | CN1102149C 4-haloalkyl-3-heterocycolyl pyridines and 4-haloalkyl-5-heterocyclylpyridines, method for producing same, composition containing same and use thereof |
| 02/25/2003 | US6525079 Antiparasitic compounds such as 4-(2,2-dibromocyclopropyl)-1-(2,6-dichloro-4-trifluoromethylphenyl)-1,2,3 -triazole |
| 02/25/2003 | US6525036 Compounds and compositions as protease inhibitors |
| 02/20/2003 | WO2003014316A2 Immunomodulatory compositions, formulations, and methods for use thereof |
| 02/20/2003 | WO2003013513A1 Stable emulsion composition |
| 02/20/2003 | WO2002048097B1 Compounds, compositions and methods for treatment of parasitic infections |
| 02/20/2003 | US20030036532 Treatment of infections caused by parasites, especially malaria. |
| 02/20/2003 | US20030035798 Prevention infections; such as colds, influenza |
| 02/20/2003 | CA2456328A1 Complexes of a short cpg-containing oligonucleotide bound to the surface of a solid phase microcarrier and methods for use thereof |
| 02/19/2003 | WO2002016574A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283874A2 Novel deoxynucleoside kinase enzyme variants |
| 02/19/2003 | EP1283716A1 Vaccine comprising a tick cement protein |
| 02/19/2003 | CN1398260A 二肽腈组织蛋白酶k抑制剂 Dipeptide nitrile cathepsin inhibitors k |
| 02/19/2003 | CA2420065A1 Methods for indentifying specifically cleavable peptides and use of such peptide sequences |
| 02/18/2003 | US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them |
| 02/18/2003 | US6521610 4-Haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclyl-pyrimidines, processes for their preparation, compositions comprising them, and their use as pesticides |
| 02/18/2003 | US6521263 From the nematode Heligmosomoides polygyrus, characterised in that the agent has molecular weight of less than 12 kDa, is resistant to proteinase K and is not bound to a polypeptide; interferes with T cell function |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012129A2 Shikimate kinase from s. aureus for drug discovery |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011310A1 Methods and compositions for control of coccidiosis |
| 02/13/2003 | WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 02/13/2003 | WO2003011266A2 Azalide antibiotic compositions |
| 02/13/2003 | WO2003011214A2 Novel methods and formulations for administration of active agents |
| 02/13/2003 | WO2002100430B1 Vaccine complex for preventing or treating leishmaniases |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/13/2003 | US20030032677 Contains peroxidic species or reaction products resulting from oxidation of geraniol via ozone; for treating horses infected with Sarcocystis protozoal infections |
| 02/13/2003 | US20030032184 Hepatocyte culture for use monitoring liver metabolism and diagnosing liver disorders |
| 02/13/2003 | US20030031659 For the treatment or prevention of a gastrointestinal infection caused by a pathogenic bacteria; for reducing insect and parasite populations in animal manure |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2451942A1 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/12/2003 | EP1283217A2 Antibodies against the IL-8 receptor, and their therapeutic uses |
| 02/12/2003 | EP1282435A2 Interleukin-1 inhibitors in the treatment of diseases |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282407A1 Delivery mechanism for the introduction of biological substances to animals |